Network analyses identify liver‐specific targets for treating liver diseases-Reference-Cited by-同舟云学术

Network analyses identify liver‐specific targets for treating liver diseases

Published:2017-08 Issue:8 Volume:13 Page:938
ISSN:1744-4292
Container-title:Molecular Systems Biology
language:en
Short-container-title:Mol Syst Biol

Author:

Lee Sunjae¹^ORCID,Zhang Cheng¹^ORCID,Liu Zhengtao¹,Klevstig Martina²,Mukhopadhyay Bani³,Bergentall Mattias²,Cinar Resat³^ORCID,Ståhlman Marcus²,Sikanic Natasha¹,Park Joshua K³,Deshmukh Sumit¹,Harzandi Azadeh M¹,Kuijpers Tim¹,Grøtli Morten⁴,Elsässer Simon J⁵,Piening Brian D⁶,Snyder Michael⁶,Smith Ulf²,Nielsen Jens¹⁷^ORCID,Bäckhed Fredrik²,Kunos George³,Uhlen Mathias¹^ORCID,Boren Jan²^ORCID,Mardinoglu Adil¹⁷^ORCID

Affiliation:

1. Science for Life Laboratory KTH – Royal Institute of Technology Stockholm Sweden

2. Department of Molecular and Clinical Medicine University of Gothenburg and Sahlgrenska University Hospital Gothenburg Sweden

3. Laboratory of Physiologic Studies National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Bethesda MD USA

4. Department of Chemistry and Molecular Biology University of Gothenburg Gothenburg Sweden

5. Department of Medical Biochemistry and Biophysics Karolinska Institutet Stockholm Sweden

6. Department of Genetics Stanford University Stanford CA USA

7. Department of Biology and Biological Engineering Chalmers University of Technology Gothenburg Sweden

Funder

Knut och Alice Wallenbergs Stiftelse

Horizon 2020 Framework Programme

Vetenskapsrådet

Seventh Framework Programme

Publisher

EMBO

Subject

Applied Mathematics,Computational Theory and Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Information Systems

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/msb.20177703

Reference57 articles.

1. Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT

2. Identification of anticancer drugs for hepatocellular carcinoma through personalized genome‐scale metabolic modeling

3. Differential expression analysis for sequence count data

4. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease

5. Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy;Medical Oncology;2024-07-15

2. Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma;Bioorganic Chemistry;2024-06

3. A promising therapy for fatty liver disease: PCSK9 inhibitors;Phytomedicine;2024-06

4. Leucine rich repeat LGI family member 3: Integrative analyses support its prognostic association with pancreatic adenocarcinoma;Medicine;2024-02-23

5. p110α-dependent hepatocyte signaling is critical for liver gene expression and its rewiring in MASLD;2024-01-10